FOXP3+ T cells in uterine sarcomas are associated with favorable prognosis, low extracellular matrix expression and reduced YAP activation

Immune Checkpoint Inhibitory Therapy in Sarcomas: Is There Light at the End of the Tunnel?

(2021) Vasiliki Siozopoulou et al.   Cancers

Mechanically activated ion channel Piezo1 modulates macrophage polarization and stiffness sensing

(2021) Hamza Atcha et al.   Nature Communications

Xiaozhang Tie Improves Intestinal Motility in Rats With Cirrhotic Ascites by Regulating the Stem Cell Factor/c-kit Pathway in Interstitial Cells of Cajal

(2020) Qiang Zhao et al.   Frontiers in Pharmacology

The Immunosuppressive Niche of Soft Tissue Sarcomas is Sustained by Tumor Associated Macrophages and Characterized by Intratumoral Tertiary Lymphoid Structures

(2020) Lingling Chen et al.   CLINICAL CANCER RESEARCH

Verteporfin Inhibits PD-L1 through Autophagy and the STAT1–IRF1–TRIM28 Signaling Axis, Exerting Antitumor Efficacy

(2020) Jiyong Liang et al.   Cancer Immunology Research

Integrated Molecular Analysis of Undifferentiated Uterine Sarcomas Reveals Clinically Relevant Molecular Subtypes

(2019) Amrei Binzer-Panchal et al.   CLINICAL CANCER RESEARCH

Metascape provides a biologist-oriented resource for the analysis of systems-level datasets

(2019) Yingyao Zhou et al.   Nature Communications

YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis

(2018) Shuai Ye et al.   CANCER RESEARCH

Prognostic value of intra-tumoral CD8+ /FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis

(2018) Kostandinos Sideras et al.   JOURNAL OF SURGICAL ONCOLOGY

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

(2018) Sanjeev Mariathasan et al.   NATURE

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

(2018) Moshe Sade-Feldman et al.   CELL

YAP/TAZ Signaling as a Molecular Link between Fibrosis and Cancer

(2018) Satoshi Noguchi et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review

(2018) Bagher Farhood et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer

(2018) Yumeng Wang et al.   Cell Reports

CD163-positive cancer cells are potentially associated with high malignant potential in clear cell renal cell carcinoma

(2017) Chaoya Ma et al.   Medical Molecular Morphology

PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis

(2017) Yi Que et al.   Journal of Cancer

QuPath: Open source software for digital pathology image analysis

(2017) Peter Bankhead et al.   Scientific Reports

Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

(2016) Takuro Saito et al.   NATURE MEDICINE

Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma

(2016) S Murakami et al.   ONCOGENE

TAZ and YAP are frequently activated oncoproteins in sarcomas

(2016) Colleen A. Fullenkamp et al.   Oncotarget

The ratio of CD8 to Treg tumor-infiltrating lymphocytes is associated with response to cisplatin-based neoadjuvant chemotherapy in patients with muscle invasive urothelial carcinoma of the bladder

(2016) Alexander S. Baras et al.   OncoImmunology

Human and Mouse CD8+CD25+FOXP3+ Regulatory T Cells at Steady State and during Interleukin-2 Therapy

(2015) Guillaume Churlaud et al.   Frontiers in Immunology

Mapping the immunosuppressive environment in uterine tumors: implications for immunotherapy

(2014) Anke Vanderstraeten et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Foxp3 expression in T regulatory cells and other cell lineages

(2014) Christel Devaud et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Management of sarcomas of the uterus

(2013) Akiva P. Novetsky et al.   CURRENT OPINION IN ONCOLOGY

Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages

(2013) Mário Henrique M. Barros et al.   PLoS One

CD8+Foxp3+ T cells share developmental and phenotypic features with classical CD4+Foxp3+ regulatory T cells but lack potent suppressive activity

(2011) Christian T. Mayer et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Human FOXP3 and cancer

(2010) F Martin et al.   ONCOGENE

Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer

(2009) Hiroyuki Suzuki et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Uterine sarcomas: A review

(2009) Emanuela D'Angelo et al.   GYNECOLOGIC ONCOLOGY

Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients

(2009) Vera M Abeler et al.   HISTOPATHOLOGY

Clinical management of uterine sarcomas

(2009) Frédéric Amant et al.   LANCET ONCOLOGY

The controversial role of tumor necrosis factor α in fibrotic diseases

(2008) Jörg H. W. Distler et al.   ARTHRITIS AND RHEUMATISM

TGF-β: A Master of All T Cell Trades

(2008) Ming O. Li et al.   CELL

CD4+CD25+FoxP3+PD1− regulatory T cells in acute and stable relapsing-remitting multiple sclerosis and their modulation by therapy

(2008) Marina Saresella et al.   FASEB JOURNAL